Fundraising Fox

Soley

South San Francisco, US · Founded 2020 · Delaware corporation · 42 employees on LinkedIn · 2 known investors

Soley Therapeutics develops proprietary imaging, AI, and automation technology to analyze cellular responses to stress and drug exposure, enabling the discovery of novel medicines and therapeutic mechanisms.

Founders & leadership

KV
Ken V. AlwynChief Financial Officer
KA
Kurosh AmeriNamed on SEC filing
YY
Yerem YeghiazariansNamed on SEC filing

Investors · 2

Reported raises · per SEC filings

Form D private placements

$20M disclosed across 1 round · 2020

$20MraisedDec 2020 · 32 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kurosh AmeriDirector
  • Yerem YeghiazariansDirector
  • Ken V. AlwynExecutive Officer, Director
Offering amount
$20M
Amount sold
$20M
First sale
Oct 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Companies competing with Soley for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Soley do?
Soley Therapeutics develops proprietary imaging, AI, and automation technology to analyze cellular responses to stress and drug exposure, enabling the discovery of novel medicines and therapeutic mechanisms.
Who are Soley's investors?
Soley's investors include Artisanal Ventures, Breyer Capital.
How much funding has Soley raised?
Soley has disclosed $20M raised across 1 round.
Where is Soley headquartered?
Soley is headquartered in South San Francisco, US.